Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$492M |
| 2 |
LLL
L3 Technologies, Inc.
LLL
|
+$392M |
| 3 |
Apple
AAPL
|
+$245M |
| 4 |
AGN
Allergan plc
AGN
|
+$238M |
| 5 |
NXP Semiconductors
NXPI
|
+$226M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$568M |
| 2 |
Coty
COTY
|
+$491M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$224M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$211M |
| 5 |
Sysco
SYY
|
+$208M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.12% |
| 2 | Technology | 11.12% |
| 3 | Financials | 10.62% |
| 4 | Consumer Discretionary | 8.46% |
| 5 | Industrials | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Intrepid Potash
IPI
$476M
| $1.5M | ﹤0.01% |
44,612
-118,737
| -73% | -$4.14M |
|
|
LN
2552
DELISTED
LINE Corporation
LN
| $1.5M | ﹤0.01% |
53,184
+42,284
| +388% | +$1.33M |
|
2553
Azenta
AZTA
$1.3B
| $1.49M | ﹤0.01% |
38,520
+6,993
| +22% | +$251K |
|
2554
iShares Core MSCI EAFE ETF
IEFA
$186B
| $1.49M | ﹤0.01% |
+24,319
| New | +$1.49M |
|
|
EVBG
2555
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $1.49M | ﹤0.01% |
16,688
-349,078
| -95% | -$27.6M |
|
2556
Sociedad Química y Minera de Chile
SQM
$19.3B
| $1.49M | ﹤0.01% |
47,753
-66,568
| -58% | -$2.27M |
|
2557
Arrow Electronics
ARW
$10.5B
| $1.49M | ﹤0.01% |
20,843
-229,077
| -92% | -$16.9M |
|
|
EDN
2558
Edenor
EDN
$1.12B
| $1.48M | ﹤0.01% |
81,648
-109,666
| -57% | -$1.99M |
|
|
CBPO
2559
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $1.48M | ﹤0.01% |
15,553
+6,845
| +79% | +$645K |
|
2560
PUT
Hasbro
HAS
$13.5B
| $1.48M | ﹤0.01% |
+14,000
| New | +$1.38M |
|
2561
American Vanguard Corp
AVD
$68.7M
| $1.48M | ﹤0.01% |
95,811
-12,896
| -12% | -$197K |
|
2562
Citi Trends
CTRN
$555M
| $1.47M | ﹤0.01% |
100,751
-26,375
| -21% | -$451K |
|
|
FONR
2563
DELISTED
Fonar
FONR
| $1.47M | ﹤0.01% |
+68,502
| New | +$1.4M |
|
2564
Smith & Wesson
SWBI
$649M
| $1.47M | ﹤0.01% |
212,301
+128,033
| +152% | +$907K |
|
2565
Quanex
NX
$825M
| $1.47M | ﹤0.01% |
77,779
-40,864
| -34% | -$685K |
|
2566
Ring Energy
REI
$307M
| $1.47M | ﹤0.01% |
452,055
+351,578
| +350% | +$1.56M |
|
2567
iShares MSCI Thailand ETF
THD
$361M
| $1.47M | ﹤0.01% |
15,334
-84,948
| -85% | -$7.67M |
|
|
PVG
2568
DELISTED
PRETIUM RESOURCES INC.
PVG
| $1.46M | ﹤0.01% |
+145,701
| New | +$1.24M |
|
|
XYZ
2569
PUT
Block Inc
XYZ
$48.9B
| $1.45M | ﹤0.01% |
+20,000
| New | +$1.4M |
|
2570
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.41B
| $1.45M | ﹤0.01% |
27,387
-1,455
| -5% | -$76.2K |
|
2571
Financial Institutions
FISI
$812M
| $1.44M | ﹤0.01% |
49,526
-42,106
| -46% | -$1.17M |
|
|
EQC
2572
DELISTED
Equity Commonwealth
EQC
| $1.44M | ﹤0.01% |
44,406
-7,298
| -14% | -$237K |
|
2573
Aldeyra Therapeutics
ALDX
$97.1M
| $1.44M | ﹤0.01% |
240,354
-146,079
| -38% | -$1.1M |
|
|
VIOT
2574
Viomi Technology
VIOT
$52.1M
| $1.43M | ﹤0.01% |
176,104
-49,491
| -22% | -$511K |
|
|
RUBY
2575
DELISTED
Rubius Therapeutics, Inc
RUBY
| $1.43M | ﹤0.01% |
+90,803
| New | +$1.47M |
|
Similar funds
Millennium Management's Q2 2019 Portfolio in Review
As of Q2 2019, Millennium Management held 4,801 positions worth $66.5B, down 0.45% from $66.8B the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.
Millennium Management's Q2 2019 filing shows 865 new, 1,488 increased, 1,571 reduced and 810 closed positions. Its largest new stake was Moody's: 638,271 shares worth $125M. The largest sale was Walt Disney, an estimated $568M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Technology and Financials.
- Millennium Management's largest Q2 2019 buy was Moody's: 638,271 shares worth $125M.
- Millennium Management added most to LyondellBasell Industries in Q2 2019, an estimated $492M increase.
- Millennium Management's biggest Q2 2019 reduction was Walt Disney, cutting an estimated $568M.
- Millennium Management fully exited Sysco in Q2 2019, selling an estimated $208M.
- Millennium Management's ten largest holdings make up 7.7% of its $66.5B portfolio in Q2 2019.
- Millennium Management opened 865 new positions and closed 810 in Q2 2019.
- Millennium Management's portfolio value fell 0.45% quarter-over-quarter to $66.5B.
Based on Millennium Management's 13F filing for Q2 2019, filed 14 Aug 2019.